HoldsUp

Dr. Eric Berg DC · 2026-06-26 · Eric Berg (host), Steve, Tashia, Edward, Amy

The Dr. Berg Show LIVE - June 26, 2026

39 research-tied claims examined: 2 contradicted 10 overstated 3 context 16 supported 8 unverified

10

Overstated

0:05:56Eric Berg (host)overstatedmoderate

Peripheral neuropathy can usually be greatly improved with benfotiamine and alpha-lipoic acid.

"could it be a peripheral neuropathy, which usually can be improved greatly with taking benfotiamine and alpha-lipoic acid." (said at 0:05:56)

While alpha-lipoic acid (ALA) and benfotiamine have been studied as pathogenetically oriented treatments primarily in diabetic peripheral neuropathy, asserting that peripheral neuropathy "usually can be improved greatly" with these supplements overstates the evidence. Systematic reviews and randomized controlled trials show that ALA provides modest short-term symptomatic relief (such as reduction in pain and paresthesias), but long-term data (such as the 4-year NATHAN 1 trial) show limited, borderline functional benefits and no clear disease-modifying or nerve-regenerative effects. For benfotiamine, evidence is limited to small, short-duration trials, and systematic reviews (including Cochrane) have found insufficient evidence to establish strong efficacy across peripheral neuropathies.

0:07:28Eric Berg (host)overstatedmoderate

Taking 50,000 IUs of vitamin D3 with magnesium and K2 for 3 days before any surgical procedure greatly improves outcomes.

"before the surgery, you definitely need to do, for like 3 days before the surgery, I would take at least 50,000 IUs of vitamin D3 with the magnesium, K2, because that would improve your outcomes greatly. Any type of surgical procedure, vitamin D, hands down, no matter what surgery, people going into it with more vitamin D will have way better outcomes." (said at 0:07:28)

While baseline vitamin D deficiency is associated with poorer postoperative recovery and higher complication rates in certain surgical settings (such as orthopedic procedures or post-CABG atrial fibrillation), evidence does not support universal high-dose supplementation (50,000 IU daily for 3 days alongside magnesium and vitamin K2) across all surgical procedures. Systematic reviews of micronutrient supplementation in perioperative care conclude that routine high-dose supplementation is not justified, recommending instead targeted screening and correction of deficiencies in high-risk patients. Furthermore, randomized controlled trials evaluating high-dose preoperative vitamin D (such as 50,000 IU) have failed to demonstrate broad improvements in functional recovery or complication rates compared to placebo.

0:29:05Eric Berg (host)overstatedvery low

High therapeutic doses of vitamin D3 administered under the Coimbra protocol can put autoimmune diseases into remission without the side effects of steroids.

"You want to find a doctor who knows the Coimbra protocol from Brazil, this Dr. Coimbra, uh, using high vitamin D. There's um It's fantastic for autoimmune because it can actually be something that won't have the side effects that the steroids have, and um if you get a doctor to help you go through that and monitor the the dose, the therapeutic doses of vitamin D3, potentially you can put that thing in remission." (said at 0:29:05)

The assertion that high-dose vitamin D3 under the Coimbra protocol puts autoimmune diseases into remission is overstated. Published literature on the Coimbra protocol consists primarily of mechanistic hypothesis papers, uncontrolled clinical series, and observational safety cohorts evaluating high doses (often exceeding 30,000 IU/day) paired with strict calcium-restricted diets. These publications describe clinical observations and safety parameters under medical monitoring, but they lack randomized, controlled comparative evidence demonstrating clinical remission or equivalence to corticosteroids. Moreover, meta-analyses of randomized controlled trials examining high-dose vitamin D3 in autoimmune conditions such as multiple sclerosis have shown no significant effect on clinical disability or relapse rates.

0:30:27Eric Berg (host)overstatedlow

Using high doses of vitamin D3 can significantly help shrink uterine fibroids.

"And using higher doses of vitamin D3, you can help uh greatly help shrink fibroids." (said at 0:30:27)

While clinical studies and meta-analyses show that vitamin D3 supplementation (typically 50,000 IU weekly for 8–12 weeks) is associated with a modest reduction or stabilization in uterine fibroid size in women with vitamin D deficiency/insufficiency, claiming it can "greatly" shrink fibroids overstates the effect. A 2024 meta-analysis of randomized controlled trials reported a modest standardized mean difference (SMD: -0.48, 95% CI: -0.66 to -0.31) in fibroid size compared to controls. Another 2024 meta-analysis found a mean percentage reduction difference of only -5.7% (95% CI: -10.63% to -0.76%) between supplemented patients and controls. Individual trials often show stabilization or small, statistically non-significant volume decreases rather than substantial shrinkage.

0:36:57Eric Berg (host)overstatedmoderate

A Japanese study demonstrated that high-dose vitamin K2 (40 to 45 milligrams) can reverse osteoporosis.

"the K2 you want it like in 40 to 45 milligrams, not micrograms, because there's been a study out of Japan that showed that when you take higher amounts of K2, you can actually uh reverse osteoporosis." (said at 0:36:57)

Japanese clinical trials evaluated high-dose vitamin K2 (menatetrenone at 45 mg/day) for postmenopausal osteoporosis. However, these trials found that 45 mg of vitamin K2 helped maintain bone mineral density (BMD) and reduce subsequent fracture risk compared to untreated controls, rather than 'reversing' osteoporosis. For example, a 24-month randomized study in Japan by Shiraki et al. (2000) showed that 45 mg/day of vitamin K2 prevented bone loss (-0.5% change in lumbar BMD vs. -3.3% in controls) and reduced clinical fractures, but noted that the treatment group did not show substantial gains in bone mineral density. Describing this effect as reversing osteoporosis overstates the therapeutic benefit.

0:37:23Eric Berg (host)overstatedmoderate

Vitamin K2 prevents calcium from depositing in soft tissues.

"And also K2 keeps the um calcium out of the soft tissues." (said at 0:37:23)

Biochemically, vitamin K (including vitamin K2) acts as an essential cofactor for the gamma-carboxylation and activation of Matrix Gla Protein (MGP), a key physiological inhibitor of soft tissue and vascular calcification. However, claiming that vitamin K2 supplementation definitively prevents calcium deposition in soft tissues overstates the clinical trial evidence. Systematic reviews and meta-analyses of randomized controlled trials indicate that while vitamin K supplementation reliably increases MGP carboxylation, it has not consistently prevented the progression of vascular or arterial calcification in clinical outcome studies.

0:39:09Eric Berg (host)overstatedmoderate

Heart arrhythmia is one of the earliest symptoms of magnesium deficiency.

"because one of the first signs of a magnesium deficiency is the heart arrhythmia issues." (said at 0:39:09)

The claim is overstated. While magnesium deficiency directly impairs myocardial electrical stability and can induce arrhythmias (including atrial fibrillation, flutter, and ventricular arrhythmias), cardiac arrhythmias are generally considered manifestations of more pronounced or severe hypomagnesemia rather than the earliest or initial symptoms. The earliest clinical signs of magnesium deficiency are typically non-specific systemic and neuromuscular symptoms, such as loss of appetite, nausea, fatigue, weakness, muscle cramps, and tremors, whereas arrhythmias and severe cardiac conduction abnormalities typically develop as depletion progresses.

0:49:37Eric Berg (host)overstatedmoderate

Loose otolith calcium crystals in the inner ear that cause dizziness can be treated with vitamin D and K2.

"these little um calcium uh pieces break off in the inner ear and they float around. They can cause disorientation and dizziness, in which case the remedy would be vitamin D and K2." (said at 0:49:37)

The primary and definitive treatment for loose otolith crystals causing benign paroxysmal positional vertigo (BPPV) is mechanical repositioning (such as the Epley or canalith repositioning maneuvers), not vitamin supplementation. Randomized controlled trials and meta-analyses show that vitamin D supplementation (often combined with calcium) can modestly reduce the rate of BPPV recurrence in patients who are deficient in vitamin D following successful repositioning maneuvers. However, vitamin D is not an acute remedy to dissolve or reposition displaced crystals, and there is no robust clinical trial evidence demonstrating that vitamin K2 treats or prevents BPPV.

0:52:30Eric Berg (host)overstatedmoderate

Nearly every person has cancer cells living in their body at any given time.

"pretty much everyone if not everyone has cancer cells living in their body." (said at 0:52:30)

The claim that nearly everyone has cancer cells in their body at any given time conflates somatic DNA mutations and cellular damage with established cancer cells, and overgeneralizes findings from occult microtumors in older adults to the entire population. While cellular mutations and clonal expansions occur continuously across the human lifespan, healthy cellular repair mechanisms and immune surveillance typically eliminate damaged cells before they acquire the hallmarks of cancer. Systematic reviews of autopsy studies demonstrate that while incidental occult micro-cancers and precursor lesions (such as latent prostate, thyroid, or in situ breast lesions) are relatively common in older adults (e.g., reaching up to ~59% in men over 79 for occult prostate cancer and ~19.5% for incidental breast neoplasia/precursors), their prevalence is low in younger individuals (e.g., ~5% in men under 30) and far from ubiquitous across the general population at any given time.

1:01:50Eric Berg (host)overstatedmoderate

Inactive forms of vitamin B6 and folic acid accumulate toxically if not supplied in their active state to individuals with genetic methylation issues.

"The same exact thing with vitamin um B6 and folic acid. So there's certain nutrients that you you need to get them in their active state uh especially if there's a genetic issue." (said at 1:01:50)

While high doses of inactive vitamin B6 (pyridoxine) can cause sensory neuropathy by competitively inhibiting active pyridoxal-5'-phosphate (PLP) and pyridoxal kinase (PDXK), this toxicity is caused by excessive dosage rather than underlying genetic methylation defects. Similarly, high intake of synthetic folic acid can result in circulating unmetabolized folic acid (UMFA), and single nucleotide polymorphisms in the folate pathway (such as MTHFR) affect one-carbon metabolism; however, current evidence does not demonstrate that inactive forms of B6 and folate accumulate toxically specifically as a result of genetic methylation issues.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.